Skip to content

Merck & Co. MRK Financing Cash Flow

Financing Cash Flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$1.56B-57.1%
Pfizer logo
PfizerPFE
-$2.86B+45.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$530M-94.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$802.2M+26.3%
Cytokinetics logo
CytokineticsCYTK
$7.77M+63.4%
Phibro Animal Health logo
Phibro Animal HealthPAHC
-$2.3M

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$317.77B+57.6%
Enterprise value$361.47B+56.9%
P/E35.6×+23.3×
P/S4.8×+1.7×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s financing cash flow?
Merck & Co. (MRK) reported financing cash flow of -$2.98B in Q1 2026.
How has Merck & Co.'s financing cash flow changed year-over-year?
Merck & Co.'s financing cash flow increased by 48.2% year-over-year, from -$5.76B to -$2.98B.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.